[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-354959-105":59,"doc-detail-354959-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","gut-microbiomedriven-colorectal-cancer-via-immune-metabolic-neural-and-endocrine-axes-reprogramming-review","Gut microbiome–driven colorectal cancer via immune, metabolic, neural, and endocrine axes reprogramming - Review","","Colorectal cancer (CRC) is a leading cause of cancer mortality worldwide, shaped by complex host–microbe interactions. This review synthesizes molecular, ecological, and translational evidence showing how gut microbial communities reprogram immune, metabolic, neural, and endocrine networks in the tumor microenvironment. CRC-associated dysbiosis enriches pathobionts and reduces protective short-chain-fatty-acid-producing commensals, promoting DNA damage, barrier disruption, metabolic rewiring, and chronic inflammation. Microbial metabolites and mutational signatures link exposures to human cancer genomes, supporting CRC as a microbiome-driven, biofilm-structured ecosystem and informing precision prevention and therapy strategies targeting the microbiota.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/gut-microbiomedriven-colorectal-cancer-via-immune-metabolic-neural-and-endocrine-axes-reprogramming-review/354959/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/gut-microbiomedriven-colorectal-cancer-via-immune-metabolic-neural-and-endocrine-axes-reprogramming-review/354959.png","ImageObject",300,407,{"name":92,"@type":93},"Olivia Brown","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-27","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How does gut dysbiosis contribute to colorectal cancer development and progression?","Question",{"text":112,"@type":113},"The review explains that CRC-associated dysbiosis enriches pathobionts and reduces protective short-chain-fatty-acid-producing commensals, driving carcinogenesis through DNA damage, epithelial barrier disruption, metabolic rewiring, and chronic inflammation that supports immune suppression and tumor growth.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What role do microbial metabolites play in linking microbiome exposure to cancer genomes?",{"text":117,"@type":113},"The review states that defined mutational signatures from bacterial metabolites, including colibactin, cytolethal distending toxin, and indolimines, directly connect microbial exposures to human cancer genomes.",{"name":119,"@type":110,"acceptedAnswer":120},"Why is establishing causality between specific microbes and CRC challenging?",{"text":121,"@type":113},"Despite strong associations, the review emphasizes that direct causality is difficult because the gut microbiota is complex and polymicrobial, limiting the straightforward application of classic Koch’s postulates.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},354959,1790153465,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},16904993612988,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","npj | bioﬁlms and microbiomes Review  \nPublished in partnership with Nanyang Technological University  \n[https://doi.org/10.1038/s41522-025-00883-8](https://doi.org/10.1038/s41522-025-00883-8)  \nGut microbiome–driven colorectal cancer via immune, metabolic, neural, and endocrine axes reprogramming  \n Check for updates  \nDisruption of  \n\n| Jhommara Bautista1,2,3, Mónica Lamas-Maceiras2,3, Camila Hidalgo-Tinoco1, Antonio Guerra-Guerrero1, Anapaula Betancourt-Velarde1 & Andrés López-Cortés1  |  |\n| --- | --- |\n| Colorectal cancer (CRC) is a leading cause of cancer mortality worldwide and is increasingly recognized as the outcome of complex host–microbe interactions. Beyond established genetic and environmental drivers, the gut microbiome has emerged as a causal and mechanistic contributor to CRC initiation, progression, and therapy response. This review synthesizes current molecular, ecological, and translational evidence to explain how gut microbial communities reprogram immune, metabolic, neural, and endocrine networks within the tumor microenvironment. CRC-associated dysbiosis is characterized by enrichment of pathobionts such as Fusobacterium nucleatum, pks⁺ Escherichia coli, and enterotoxigenic Bacteroides fragilis, and by loss of protective, short-chain-fattyacid-producing commensals. These microbes promote carcinogenesis through genotoxin-induced DNA damage, epithelial barrier disruption, metabolic rewiring, and chronic inﬂammation that collectively sustain immune suppression and tumor growth. Deﬁned mutational signatures from bacterial metabolites, including colibactin, cytolethal distending toxin, and indolimines, now directly link microbial exposures to human cancer genomes. By integrating these ﬁndings, this review conceptualizes CRC as a bioﬁlm-structured, microbiome-driven ecosystem disease, where polymicrobial consortia coordinate barrier breakdown, immune evasion, and metabolic cooperation. Finally, we highlight emerging microbiota-targeted strategies, including dietary modulation, pre-and probiotics, postbiotics, bacteriophage therapy, engineered live biotherapeutics, and fecal microbiota transplantation, that translate these insights into precision prevention and therapy. Through this integrative framework, the review aims to reposition the microbiome from a correlative feature to a tractable determinant of CRC pathogenesis and treatment response. |  |\n| Colorectal cancer (CRC) is not only a major global health burden but also a disease increasingly understood as the product of complex host–microbe interactions. It ranks as the third most common malignancy and the second leading cause of cancer-related mortality, with an increasing incidence in early-onset cases, particularly in industrialized nations and transitioning economies 1. Early-life microbial colonization critically shapes immune development and long-term disease risk. Birth mode, breastfeeding, maternal microbiota, and early antibiotics inﬂuence microbial diversity during a sensitive period, where disruptions can lead to persistent dysbiosis, | impaired tolerance, and higher susceptibility to inﬂammatory and neoplastic diseases later in life2–4.\u003Cbr>The human gastrointestinal tract harbors a complex microbial ecosystem exceeding 3.8 × 10¹³ microorganisms, predominantly belonging to the phyla Bacteroidetes, Firmicutes, Actinobacteria, Proteobacteria, Fusobacteriota, and Verrucomicrobiota, which collectively maintain intestinal homeostasis, nutrient metabolism, and immune regulation5.\u003Cbr>this balance, or dysbiosis, has been associated with shifts toward pathogenic or pro-inﬂammatory taxa, leading to chronic inﬂammation, epithelial barrier dysfunction, and exposure of host tissues to microbial toxins and |\n\n1Cancer Research Group (CRG), Faculty of Medicine, Universidad de Las Américas, Quito, Ecuador. 2Instituto de Investigación Biomédica de A Coruña (INIBIC), Complexo Hospitalario Universitario deA Coruña (CHUAC), Universidade da Coruña (UDC), A Coruña, E","cbCaiit9SQTGbgfO","https://ap.wps.com/l/cbCaiit9SQTGbgfO","pdf",2132179,22,"English","# Gut microbiome–driven colorectal cancer overview\n## Dysbiosis and tumor-promoting mechanisms\n## Microbial metabolites, mutational signatures, and causality\n## Microbiome-targeted prevention and therapy strategies","[{\"question\":\"How does gut dysbiosis contribute to colorectal cancer development and progression?\",\"answer\":\"The review explains that CRC-associated dysbiosis enriches pathobionts and reduces protective short-chain-fatty-acid-producing commensals, driving carcinogenesis through DNA damage, epithelial barrier disruption, metabolic rewiring, and chronic inflammation that supports immune suppression and tumor growth.\"},{\"question\":\"What role do microbial metabolites play in linking microbiome exposure to cancer genomes?\",\"answer\":\"The review states that defined mutational signatures from bacterial metabolites, including colibactin, cytolethal distending toxin, and indolimines, directly connect microbial exposures to human cancer genomes.\"},{\"question\":\"Why is establishing causality between specific microbes and CRC challenging?\",\"answer\":\"Despite strong associations, the review emphasizes that direct causality is difficult because the gut microbiota is complex and polymicrobial, limiting the straightforward application of classic Koch’s postulates.\"}]","Gut microbiome–driven colorectal cancer via immune, metabolic, neural, and endocrine axes reprogramming - Review | PDF",1790115057,55,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ea9eb89206b08f24d6e6de231fe9cc96.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4205a039ddee55517d0fdb528380b0f3.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/40c3a32523a8f06d3fdc7130d06ccad6.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5bdc3082e5f416d5403b33d0bb7a8412.webp",980,1301]